可降解材料在心血管介入治疗中的应用进展
Application Progress of Degradable Materials in Cardiovascular Intervention
DOI: 10.12677/ACM.2022.12101307, PDF,    国家自然科学基金支持
作者: 田 认：新疆医科大学，新疆 乌鲁木齐；陈 铀*：新疆医科大学第一附属医院心脏中心，新疆 乌鲁木齐
关键词: 可降解材料；支架；封堵器；生物相容性；Biodegradable Material； Stent； Occluder； Biocompatibility
摘要: 生物可降解材料因具有相容性良好、材料本身及降解产物无毒、机械支撑性能适当和降解速度可控等特性，目前已广泛应用到冠状动脉支架及封堵器领域，使心血管介入治疗步入崭新的阶段，给现代医学带来了极大进步。本文系统地综述了各种可降解材料在心血管介入治疗中的应用进展，包括降解特性、临床实践、随访统计、前景展望等。
Abstract: Biodegradable materials have been widely used in the field of coronary stents due to their good compatibility, non-toxic materials and degradation products, appropriate mechanical support per-formance, and controllable degradation speed, taking percutaneous transluminal cardiovascular intervention to a new stage, and bringing great progress to modern medicine. This article system-atically reviews the application progress of various degradable materials in cardiovascular inter-ventional therapy, which includes degradation characteristics, clinical practice, follow-up statistics, prospects and so on.
文章引用：田认, 陈铀. 可降解材料在心血管介入治疗中的应用进展[J]. 临床医学进展, 2022, 12(10): 9037-9043. https://doi.org/10.12677/ACM.2022.12101307

参考文献

[1] Woudstra, P., Grundeken, M.J., Kraak, R.P., Hassell, M.E., Arkenbout, E.K., Baan, J., Vis, M.M., Koch, K.T., Tijssen, J.G., Piek, J.J., de Winter, R.J., Henriques, J.P. and Wykrzykowska, J.J. (2014) Amsterdam Investigator-Initiate D Ab-sorb Strategy All-Comers Trial (AIDA Trial): A Clinical Evaluation Comparing the Efficacy and Performance of ABSORB Everolimus-Eluting Bioresorbable Vascular Scaffold Strategy vs the XIENCE Family (XIENCE PRIME or XIENCE Xpedition) Everolimus-Eluting Coronary Stent Strategy in the Treatment of Coronary Lesions in Consecutive All-Comers: Rationale and Study Design. American Heart Journal, 167, 133-140. [Google Scholar] [CrossRef] [PubMed]
[2] Quinlan, E., López-Noriega, A., Thompson, E., Kelly, H.M., Cryan, S.A. and O’Brien, F.J. (2015) Development of Collagen-Hydroxyapatite Scaffolds Incorporating PLGA and Alginate Microparticles for the Controlled Delivery of rhBMP-2 for Bone Tissue Engineering. Journal of Controlled Release: Of-ficial Journal of the Controlled Release Society, 198, 71-79. [Google Scholar] [CrossRef] [PubMed]
[3] Alizadeh-Osgouei, M., Li, Y. and Wen, C. (2018) A Compre-hensive Review of Biodegradable Synthetic Polymer-Cera- mic Composites and Their Manufacture for Biomedical Ap-plications. Bioactive Materials, 4, 22-36. [Google Scholar] [CrossRef] [PubMed]
[4] Ulery, B.D., Nair, L.S. and Laurencin, C.T. (2011) Biomedi-cal Applications of Biodegradable Polymers. Journal of Polymer Science, Part B: Polymer Physics, 49, 832-864. [Google Scholar] [CrossRef] [PubMed]
[5] 傅娜, 罗晓丁, 焦铁军, 等. 骨组织工程中应用的聚己内酯-聚乙二醇-聚己内酯静电纺丝支架[J]. 中国组织工程研究, 2019, 23(22): 3445-3450.
[6] Sarker, M.D., Naghieh, S., Sharma, N.K., Ning, L. and Chen, X. (2019) Bioprinting of Vascularized Tissue Scaffolds: Influence of Biopolymer, Cells, Growth Factors, and Gene Delivery. Journal of Healthcare Engineering, 2019, Article ID: 9156921. [Google Scholar] [CrossRef] [PubMed]
[7] Serruys, P.W., Ormiston, J.A., Onuma, Y., Regar, E., Gonzalo, N., Garcia-Garcia, H.M., Nieman, K., Bruining, N., Dorange, C., Miquel-Hébert, K., Veldhof, S., Webster, M., Thuesen, L. and Dudek, D. (2009) A Bioabsorbable Everolimus-Eluting Coronary Stent System (ABSORB): 2-Year Outcomes and Results from Multiple Imaging Methods. The Lancet (London, England), 373, 897-910. [Google Scholar] [CrossRef] 
[8] Ali, Z.A., Serruys, P.W., Kimura, T., Gao, R., Ellis, S.G., Kereiakes, D.J., Onuma, Y., Simonton, C., Zhang, Z. and Stone, G.W. (2017) 2-Year Outcomes with the Absorb Biore-sorbable Scaffold for Treatment of Coronary Artery Disease: A Systematic Review and Meta-Analysis of Seven Ran-domised Trials with an Individual Patient Data Substudy. The Lancet (London, England), 390, 760-772. [Google Scholar] [CrossRef] 
[9] Kereiakes, D.J., Ellis, S.G., Metzger, C., Caputo, R.P., Rizik, D.G., Teirstein, P.S., Litt, M.R., Kini, A., Kabour, A., Marx, S.O., Popma, J.J., McGreevy, R., Zhang, Z., Simonton, C., Stone, G.W. and ABSORB III Investigators (2017) 3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds: The ABSORB III Trial. Journal of the American College of Cardiology, 70, 2852-2862. [Google Scholar] [CrossRef] [PubMed]
[10] Xu, K., Fu, G., Xu, B., Zhou, Y., Su, X., Liu, H., Zhang, Z., Yu, B., Wang, X., Han, Y. and NeoVas OPC Investigators (2019) Safety and Efficacy of the Novel Sirolimus-Eluting Biore-sorbable Scaffold for the Treatment of de Novo Coronary Artery Disease: One-Year Results from a Prospective Pa-tient-Level Pooled Analysis of NeoVas Trials. Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography & Interventions, 93, 832-838. [Google Scholar] [CrossRef] [PubMed]
[11] Han, Y., Xu, B., Fu, G., Wang, X., Xu, K., Jin, C., Tao, L., Li, L., Hou, Y., Su, X., Fang, Q., Chen, L., Liu, H., Wang, B., Yuan, Z., Gao, C., Zhou, S., Sun, Z., Zhao, Y., Guan, C. and NeoVas Randomized Controlled Trial Investigators (2018) A Randomized Trial Comparing the NeoVas Sirolimus-Eluting Bioresorbable Scaffold and Metallic Everolimus-Eluting Stents. JACC. Cardiovascular Interventions, 11, 260-272. [Google Scholar] [CrossRef] [PubMed]
[12] Han, Y., Xu, K., Xu, B., Fu, G., Wang, X., Li, Y. and NeoVas Randomized Controlled Trial Investigators (2021) Comparison between a Novel Sirolimus-Eluting Bioresorbable Scaffold with Everolimus-Eluting Metallic Stent in Patients with Cor-onary Artery Disease: Three-Year Follow-Up from the NeoVas RCT Study. European Heart Journal, 42, ehab724.2139. [Google Scholar] [CrossRef] 
[13] Song, L., Sun, Z., Guan, C., Yan, H., Yu, M., Cui, J., Mu, C., Qiu, H., Tang, Y., Zhao, Y., Qiao, S., Suryapranata, H., Gao, R., Xu, B. and FUTURE-I Investigators (2020) First-in-Man Study of a Thinner-Strut Sirolimus-Eluting Bioresorbable Scaffold (FUTURE-I): Three-Year Clinical and Imaging Outcomes. Catheterization and Cardiovascular Interventions, 95, 648-657. [Google Scholar] [CrossRef] [PubMed]
[14] Song, L., Xu, B., Chen, Y., Zhou, Y., Jia, S., Zhong, Z., Su, X., Ma, Y., Zhang, Q., Liu, J., Wang, Y., Guan, C., Zheng, M., Qiao, S., Gao, R. and FUTURE-II Trial Investigators (2021) Thinner Strut Sirolimus-Eluting BRS versus EES in Patients with Coronary Artery Disease: FUTURE-II Trial. JACC Cardio-vascular Interventions, 14, 1450-1462. [Google Scholar] [CrossRef] [PubMed]
[15] 梅昕, 马凤森, 喻炎, 等. 高分子可降解生物材料的降解研究进展[J]. 材料导报, 2016(S1): 298-303.
[16] 东家慧, 谭丽丽, 杨柯. 可降解镁基金属骨缺损修复材料的研究探索[J]. 金属学报, 2017, 53(10): 1197-1206.
[17] 郑玉峰, 杨宏韬. 血管支架用可降解金属研究进展[J]. 金属学报, 2017, 53(10): 1227-1237.
[18] Yang, J., Koons, G.L., Cheng, G., Zhao, L., Mikos, A.G. and Cui, F. (2018) A Review on the Exploitation of Biodegradable Magnesium-Based Composites for Medical Applications. Biomedical Materials (Bristol, England), 13, Article ID: 022001. [Google Scholar] [CrossRef] 
[19] Haude, M., Erbel, R., Erne, P., Verheye, S., Degen, H., Vermeersch, P., Weissman, N., Prati, F., Bruining, N., Waksman, R. and Koolen, J. (2016) Safety and Performance of the Drug-Eluting Absorbable Metal Scaffold (DREAMS) in Patients with de Novo Coronary Lesions: 3-Year Results of the Prospective, Multicentre, First-in-Man BIOSOLVE-I Trial. EuroIntervention, 12, e160-e166. [Google Scholar] [CrossRef] 
[20] Haude, M., Ince, H., Abizaid, A., Toelg, R., Lemos, P.A., von Birgelen, C., Christiansen, E.H., Wijns, W., Neumann, F.J., Kaiser, C., Eeckhout, E., Lim, S.T., Escaned, J., Onuma, Y., Garcia-Garcia, H.M. and Waksman, R. (2016) Sustained Safety and Performance of the Second-Generation Drug-Eluting Absorbable Metal Scaffold in Patients with de Novo Coronary Lesions: 12-Month Clinical Results and An-giographic Findings of the BIOSOLVE-II First-in-Man Trial. European Heart Journal, 37, 2701-2709. [Google Scholar] [CrossRef] [PubMed]
[21] Xie, K., Wang, L., Guo, Y., Zhao, S., Yang, Y., Dong, D., Ding, W., Dai, K., Gong, W., Yuan, G. and Hao, Y. (2021) Effectiveness and Safety of Biodegradable Mg-Nd-Zn-Zr Alloy Screws for the Treatment of Medial Malleolar Fractures. Journal of Orthopaedic Translation, 27, 96-100. [Google Scholar] [CrossRef] [PubMed]
[22] Hermawan, H., Dubé, D. and Mantovani, D. (2010) Degradable Metallic Biomaterials: Design and Development of Fe-Mn Alloys for Stents. Journal of Biomedical Materials Research. Part A, 93, 1-11.
[23] Qi, Y., Qi, H., He, Y., Lin, W., Li, P., Qin, L., Hu, Y., Chen, L., Liu, Q., Sun, H., Liu, Q., Zhang, G., Cui, S., Hu, J., Yu, L., Zhang, D. and Ding, J. (2018) Strategy of Metal-Polymer Composite Stent to Accelerate Bio-degradation of Iron-Based Biomaterials. ACS Applied Materials & Interfaces, 10, 182-192. [Google Scholar] [CrossRef] [PubMed]
[24] Zheng, J.F., Qiu, H., Tian, Y., Hu, X.Y., Luo, T., Wu, C., Tian, Y., Tang, Y., Song, L.F., Li, L., Xu, L., Xu, B. and Gao, R.L. (2019) Preclinical Evaluation of a Novel Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold in Porcine Coronary Artery at 6 Months. JACC. Cardiovascular Interventions, 12, 245-255. [Google Scholar] [CrossRef] [PubMed]
[25] Jalal, Z., Hascoet, S., Baruteau, A.E., Iriart, X., Kreitmann, B., Bou-djemline, Y. and Thambo, J.B. (2016) Long-Term Complications after Transcatheter Atrial Septal Defect Closure: A Re-view of the Medical Literature. The Canadian Journal of Cardiology, 32, 1315.e11-1315.e18. [Google Scholar] [CrossRef] [PubMed]
[26] Gordon, B.M. and Moore, J.W. (2009) Nickel for Your Thoughts: Survey of the Congenital Cardiovascular Interventional Study Consortium (CCISC) for Nickel Allergy. The Journal of Invasive Cardiology, 21, 326-329.
[27] Philip Saul, J., Kanter, R.J., Writing Committee, Abrams, D., Asirvatham, S., Bar-Cohen, Y., Blaufox, A.D., Cannon, B., Clark, J., Dick, M., Freter, A., Kertesz, N.J., Kirsh, J.A., Kugler, J., LaPage, M., McGowan, F.X., Miyake, C.Y., Nathan, A., Papagiannis, J., Paul, T. and Zimmerman, F. (2016) PACES/HRS Ex-pert Consensus Statement on the Use of Catheter Ablation in Children and Patients with Congenital Heart Disease: De-veloped in Partnership with the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm So-ciety (HRS). Endorsed by the Governing Bodies of PACES, HRS, the American Academy of Pediatrics (AAP), the American Heart Association (AHA), and the Association for European Pediatric and Congenital Cardiology (AEPC). Heart Rhythm, 13, e251-e289. [Google Scholar] [CrossRef] [PubMed]
[28] Abraham, G.A., Murray, J., Billiar, K. and Sullivan, S.J. (2000) Evaluation of the Porcine Intestinal Collagen Layer as a Biomaterial. Journal of Biomedical Materials Research, 51, 442-452. [Google Scholar] [CrossRef] 
[29] Jux, C., Bertram, H., Wohlsein, P., Bruegmann, M. and Paul, T. (2006) Interventional Atrial Septal Defect Closure Using a Totally Biore-sorbable Occluder Matrix: Development and Preclinical Evaluation of the BioSTAR Device. Journal of the American College of Cardiology, 48, 161-169. [Google Scholar] [CrossRef] [PubMed]
[30] Mullen, M.J., Hildick-Smith, D., De Giovanni, J.V., Duke, C., Hillis, W.S., Morrison, W.L. and Jux, C. (2006) BioSTAR Evaluation STudy (BEST): A Prospective, Multicenter, Phase I Clinical Trial to Evaluate the Feasibility, Efficacy, and Safety of the BioSTAR bio-absorbable Septal Repair Implant for the Closure of Atrial-Level Shunts. Circulation, 114, 1962-1967. [Google Scholar] [CrossRef] 
[31] Happel, C.M., Laser, K.T., Sigler, M., Kececioglu, D., Sandica, E. and Haas, N.A. (2015) Single Center Experience: Implantation Failures, Early, and Late Complications after Implantation of a Partially Biodegradable ASD/PFO-Device (BioStar®). Catheterization and Cardiovascular In-terventions, 85, 990-997. [Google Scholar] [CrossRef] [PubMed]
[32] 陈桂, 杨立宝, 关静, 张宝祥, 蔡海娇, 王胜难. 生物可降解材料及其在生物医学上的应用[J]. 新材料产业, 2018(12): 38-42.
[33] Ulery, B.D., Nair, L.S. and Lau-rencin, C.T. (2001) Biomedical Applications of Biodegradable Polymers. Journal of Polymer Science Part B: Polymer Physics, 49, 832-864.
[34] Liu, S.J., Peng, K.M., Hsiao, C.Y., Liu, K.S., Chung, H.T. and Chen, J.K. (2011) Novel Bi-odegradable Polycaprolactone Occlusion Device Combining Nanofibrous PLGA/Collagen Membrane for Closure of Atrial Septal Defect (ASD). Annals of Biomedical Engineering, 39, 2759-2766. [Google Scholar] [CrossRef] [PubMed]
[35] Duong-Hong, D., Tang, Y.D., Wu, W., Venkatraman, S.S., Boey, F., Lim, J. and Yip, J. (2010) Fully Biodegradable Septal Defect Occluder—A Double Umbrella Design. Catheterization and Cardiovascular Interventions, 76, 711-718. [Google Scholar] [CrossRef] [PubMed]

为你推荐